BATS:HELX Franklin Genomic Advancements ETF (HELX) Price, Holdings, & News $30.63 +3.48 (+12.80%) Closing price 09/5/2025 03:55 PM EasternExtended Trading$30.64 +0.01 (+0.02%) As of 09/5/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartHoldingsOwnershipRatingsBuy This Stock About Franklin Genomic Advancements ETF (BATS:HELX) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get HELX alerts:Sign Up Key Stats Today's Range$27.55▼$27.5550-Day Range$27.01▼$30.6352-Week Range$23.74▼$33.93Volume2,058 shsAverage Volume3,767 shsMarket Capitalization$12.25 millionAssets Under Management$16.84 millionDividend YieldN/ANet Expense Ratio0.50%Aggregate RatingModerate Buy ETF Overview The Franklin Genomic Advancements ETF (HELX) is an exchange-traded fund that is based on the Solactive Genomics index. The fund is an actively managed portfolio of global equity securities of companies relevant to genomic discovery. HELX was launched on Feb 25, 2020 and is managed by Franklin Templeton. Read More Franklin Genomic Advancements ETF ExpensesTypeHELXTheme ETFsEquity ETFsBATS ETFsAll ETFsManagement Fee0.50%0.57%0.56%0.57%0.53%Other Expenses0.00%0.57%0.56%0.48%0.56%Total Expense0.50%0.74%0.76%0.71%0.73%Fee Waiver0.00%-0.76%-0.66%-0.46%-0.63%Net Expense0.50%0.60%0.63%0.64%0.60% Receive HELX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Franklin Genomic Advancements ETF and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. HELX ETF News HeadlinesFranklin Genomic Advancements ETF - Markets InsiderJuly 23, 2025 | markets.businessinsider.comFranklin Emerging Markets UCITS ETF (FLXE)September 18, 2024 | investing.com+2,400% return last time this happenedPorter Stansberry has built his reputation on bold predictions that challenge the mainstream — from the 2007 financial crisis to the dollar’s ongoing decline. Now, he and his top analyst say they’ve uncovered what could be the “next MicroStrategy” moment. Back in 2020, MicroStrategy quietly pivoted into Bitcoin, and the result was a 2,400% gain for investors in just over five years. Today, Porter believes a little-known financial services firm could be set up for a similar asymmetric move — one with multiple catalysts converging in the months ahead.September 6 at 2:00 AM | Porter & Company (Ad)Franklin Ethereum ETF (EZET)August 2, 2024 | finance.yahoo.comChainlink Integration Enhances Transparency for 21Shares’ Ether ETFJuly 30, 2024 | msn.comFranklin Catholic Princ Em Sov Ucits Etf Share Price (CATHEM.MI)April 23, 2024 | lse.co.ukSee More Headlines HELX ETF - Frequently Asked Questions How have HELX shares performed this year? Franklin Genomic Advancements ETF's stock was trading at $28.85 at the start of the year. Since then, HELX stock has increased by 6.2% and is now trading at $30.6340. Who are Franklin Genomic Advancements ETF's major shareholders? Top institutional investors of Franklin Genomic Advancements ETF include Osaic Holdings Inc. (0.78%) and Raymond James Financial Inc. (0.38%). How do I buy shares of Franklin Genomic Advancements ETF? Shares of HELX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Franklin Genomic Advancements ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that Franklin Genomic Advancements ETF investors own include Merck & Co., Inc. (MRK), Abiomed (ABMD), Catalent (CTLT), iShares iBonds Dec 2025 Term Muni Bond ETF (IBMN), Net Element (NETE), Novavax (NVAX) and AbbVie (ABBV). Fund Details IssuerFranklin Templeton Investments Fund NameFranklin Genomic Advancements ETF Tax ClassificationRegulated Investment Company Stock ExchangeBATSCurrent SymbolBATS:HELX Inception Date2/25/2020 Fund ManagerMatthew J.Moberg, Joyce Lin WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkN/A CategoryStrategy FocusTheme Development LevelBlended Development RegionGlobal Number of Holdings68 Fund Statistics Assets Under Management$16.84 million Average Daily Volume$0.00 Discount/Premium0.00% Administrator, Advisor and Custodian AdministratorFranklin Templeton Services, LLC AdvisorFranklin Advisers, Inc. CustodianState Street Bank and Trust Company DistributorFranklin Templeton Distributors, Inc. Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerCitadel Miscellaneous Outstanding Shares400,000Beta1.05 Creation Unit50,000 Creation Fee$200.00 Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report Top 10 HELX HoldingsNatera (NASDAQ:NTRA)Holding Weight: 6.08%Alnylam Pharmaceuticals (NASDAQ:ALNY)Holding Weight: 4.88%Guardant Health (NASDAQ:GH)Holding Weight: 4.65%Medpace (NASDAQ:MEDP)Holding Weight: 4.42%Insmed (NASDAQ:INSM)Holding Weight: 4.03%Samsung Biologics Co.,Ltd.Holding Weight: 3.83%Krystal Biotech (NASDAQ:KRYS)Holding Weight: 3.43%Vertex Pharmaceuticals (NASDAQ:VRTX)Holding Weight: 3.42%Us DollarHolding Weight: 3.15%Corteva (NYSE:CTVA)Holding Weight: 3.04%Full Holdings DetailsHELX Sector ExposureHELX Industry Exposure This page (BATS:HELX) was last updated on 9/6/2025 by MarketBeat.com Staff From Our PartnersStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredScientists Discover Untapped Energy Source in Heart of USACrash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | SponsoredThe man running the U.S. dollar… is hoarding goldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredWall Street Legend Names #1 ‘Hidden’ AI Stock50-year Wall Street legend says to forget NVDA. For the biggest potential gains, it's time to move your money ...Chaikin Analytics | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredOdd “310F trade” doubles investor’s money in just 3 days?Have you heard of 310F? This unusual trade setup has quietly delivered one of the most consistent profit st...Eagle Publishing | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Franklin Genomic Advancements ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Franklin Genomic Advancements ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HELX Stock Alerts